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Abstract
Cascades of transcriptional regulation are the common source of the forward drive in all 
developmental systems. Increases in complexity and specificity of gene expression at successive 
stages are based on the collaboration of varied combinations of transcription factors already 
expressed in the cells to turn on new genes, and the logical relationships between the transcription 
factors acting and becoming newly expressed from stage to stage are best visualized as gene 
regulatory networks. However, gene regulatory networks used in different developmental contexts 
underlie processes that actually operate through different sets of rules, which affect the kinetics, 
synchronicity, and logical properties of individual network nodes. Contrasting early embryonic 
development in flies and sea urchins with adult mammalian hematopoietic development from stem 
cells, major differences are seen in transcription factor dosage dependence, the silencing or 
damping impacts of repression, and the impact of cellular regulatory history on the parts of the 
genome that are accessible to transcription factor action in a given cell type. These different 
features not only affect the kinds of models that can illuminate developmental mechanisms in the 
respective biological systems, but also reflect the evolutionary needs of these biological systems to 
optimize different aspects of development.
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1. General and particular gene regulatory network templates for 
development
A prophetic insight into the way the genome regulates development began to take shape in a 
set of papers published by Roy J. Britten and Eric H. Davidson from 1969–1973 (Davidson 
and Britten 1973; Britten and Davidson 1971, 1969). Recognizing the primacy of differential 
gene expression for development, they postulated the existence of genomically encoded 
regulatory molecules that could act combinatorially on specialized regulatory DNA 
sequences, distinct from protein-coding sequences, to control target gene expression in a cell 
type-specific way. Because these genomically encoded regulators themselves need to have 
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their own expression controlled, the progressive diversification of cell types that is integral 
to development logically implies the existence of a hierarchical causal network for gene 
expression control with computer-like information processing at each regulatory node (Yuh 
et al. 1998; Markstein et al. 2004; Stanojevic et al. 1991). Britten and Davidson formulated 
such a network long before there was technology available to identify its actual components 
and modes of operation (Davidson and Britten 1973; Britten and Davidson 1969). In its 
general sense, this network formulation has been confirmed triumphantly by the molecular 
biology of the succeeding 45 years (Briscoe and Small 2015; Simoes-Costa and Bronner 
2015; Clark et al. 2014; Hobert 2014; Peter et al. 2012; Bonzanni et al. 2013; Kueh and 
Rothenberg 2012; Chen et al. 2012; Jaeger 2011; Laslo et al. 2008; Oliveri et al. 2008; 
Stathopoulos and Levine 2005a; Meulemans and Bronner-Fraser 2004; Davidson et al. 
2002a).
The crucial elements that have made it possible to reveal gene network circuitries that 
operate in different developmental systems have been (1) high definition of the biological 
system in terms of cell types present at different timepoints; (2) extensive identification of 
relevant gene products expressed in these cells at different time points; (3) application of 
perturbations that can acutely remove or manipulate candidate regulatory molecules at 
relevant time points; and (4) ways to measure the impact of these perturbations 
quantitatively on the other genes in the system. These approaches have provided a wealth of 
data to show that the key regulatory molecules for early embryonic differentiation are 
proteins that bind DNA sequence-specifically to control gene expression, i.e. transcription 
factors. To validate how these transcription factors are actually working on the genes they 
control, it has also been vital (5) to use molecular genomic technology to identify the 
regulatory DNA of the affected target genes and (6) to use targeted mutation and gene 
transfer strategies to map the sequences through which the effects of the transcription factors 
are mediated. These six elements have been powerfully applied to systems as diverse in 
function and phylogeny as early embryonic axis formation in Drosophila (Chen et al. 2012; 
Jaeger 2011; Stathopoulos and Levine 2005b), the chick and lamprey neural crest (Simoes-
Costa and Bronner 2015; Nikitina et al. 2008), the photoreceptor patterning of eyes (Viets et 
al. 2016; Brzezinski and Reh 2015), and the sea urchin early embryo endomesoderm 
patterning and differentiation (Peter and Davidson 2011b; Oliveri, Tu, and Davidson 2008). 
Eloquent summaries of multiple partial networks and their components, together with 
extensions of the theoretical implications of these networks to unsolved problems in 
development and evolution have been presented by Davidson and colleagues (Peter and 
Davidson 2015, 2011a; Davidson 2010; Erwin and Davidson 2009; Davidson 2006).
2. What network models tell us
There is little doubt that ultimately there are gene networks that drive development. To be 
understood, these can be embodied in logical connectivity models that represent the ways in 
which each gene activated in the course of development subsequently affects the expression 
of other genes in the network, and any dependencies of each of those effects on the activities 
of other genes (AND or OR logic). But the network models that can be constructed by 
experimental application of the six elements described above most often remain incomplete 
in important respects. First, the ranges of target genes examined rarely include all the genes 
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in the genome. Most genes are not relevant to a given developmental choice or progression 
step and so some of the art of network analysis is to use sufficient prior knowledge to focus 
on genes that are most likely to be functionally important – but prior knowledge is not 
infallible or clairvoyant. Second, the responses to perturbation that define one gene as being 
downstream of another are not always simple or direct in fact. Although an initial network 
model can show that a perturbation affects a given gene, the actual mechanism through 
which the effect is seen can go through multiple intermediate steps that are themselves 
contingent on other genes. In a common problem, a gene that is only expressed in a 
particular cell type often appears, spuriously, to be regulated by any transcription factor that 
affects generation of that cell type. Third, it is not always straightforward to determine 
whether a functional response of a gene is significant. Transcription factors can work on 
targets via “additive OR” logic, i.e., where they enhance expression even where they are not 
absolutely required for expression. Such quantitative effects may be important biologically 
even if they are not required for all target expression, but measurement error can give false 
negative results. Finally, even when transcription factors work on target genes, they can 
work through a variety of different biochemistries, and this can complicate the network 
analysis as discussed in much more detail below.
How much value, then, can one get from provisional gene network models, such as those 
that can be constructed with a “reasonable” amount of experimental effort? And how much 
effort beyond this is worth spending to make networks more complete? Even incomplete 
network models are indeed useful. They are crucial to capture large bodies of complex 
experimental results in a comprehensive way. They can clarify understanding of biological 
relationships that do not fit a preconceived notion: for example, they can show that if several 
genes failed to fit in a clear linear epistasis pathway, it may be because the genes actually are 
engaged in a feedback circuit. Provisional gene network models are also operationally 
powerful to point the way to experiments that improve understanding. Often, a real network 
circuit will turn out to be simpler than initial results suggest, for example if one of the noted 
inputs actually works on a target gene by way of another. The experiments needed to 
indicate the right simplification become evident by looking at the model. By making models 
and comparing them with observed gene expression patterns, one can also see what kinds of 
functions are missing, in order to account for the actual expression trends of each target 
relative to its proposed inputs.
3. Network completeness: success within reach
Incompleteness clearly limits the accuracy of a network model in its ability to explain or 
predict the actual biological process. If a key positive or negative regulator is not identified, 
its role will remain either unexplained or inaccurately assigned to another factor or factors 
that do(es) not actually carry out the needed function. In the case of explaining the 
development of early embryos, the network model cannot be predictive unless it accounts for 
the availability of maternally derived molecules pre-loaded into the egg during oogenesis, 
which can exert extremely powerful functions in many animals (even if not in mammals). In 
the case of explaining differentiation from long-term adult stem cells as described below, a 
network model similarly may not explain gene expression dynamics unless initial silenced 
states, enforced by repressive mechanisms involved in “stem-ness”, are taken into account 
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(Hodges et al. 2011; Oguro et al. 2010; Pietersen and van Lohuizen 2008; Maier et al. 2004; 
Tagoh et al. 2004). Another form of incompleteness is a failure to understand the logic of a 
given input into its target. This is especially important to acknowledge in view of the way 
transcription factors actually collaborate to regulate target genes. Not all “sufficient” inputs, 
as defined by gain of function experiments, are also “necessary”; and similarly, not all 
“necessary” inputs, as defined by loss of function experiments, are “sufficient”. At the 
extremes, two inputs might work by “AND” logic (both necessary, neither sufficient) or 
“OR” logic (neither necessary, either sufficient) (Istrail et al. 2007), but in reality the 
behavior can be intermediate between these extremes, or bimodal.
Completeness can be approached by two complementary strategies. One “building out” 
strategy is to analyze increasing numbers of network connections until the results that can be 
computed for the behavior of the known network are predictive of the actual biological 
system’s behaviors under all conditions (Schutte et al. 2016; Clark and Akam 2016; 
Bonzanni et al. 2013; Peter, Faure, and Davidson 2012; Jaeger 2011; Davidson et al. 2002b). 
Another “whole genome catalog” possibility is to start from all the genes expressed in the 
genome of the cells within the system, and then to define the developmentally relevant 
inputs to all these genes to the point that their expression is understood (Hughes et al. 2014; 
May et al. 2013; Zhang et al. 2013; Ciofani et al. 2012; Novershtern et al. 2011). Whereas 
both strategies would have seemed fantastic to researchers as recently as 15 years ago, they 
have become feasible in principle due to advances in methods for measuring gene expression 
and genome-wide transcription factor binding across the whole genome, and methods for 
inducing targeted mutation or antagonism of nearly any gene in the genome. The closest 
approach to a success for complete network analysis has been in the sea urchin 
endomesoderm network, which was solved to a very high criterion of success by the 
building-out strategy. To measure its approach to completeness, the key was to devise a kind 
of computational modeling that would determine how well the sum of existing network 
connectivity knowledge could perform in predicting gene expression. Without fitting model 
connection parameters to actual gene expression data, Peter, Faure and Davidson instead 
used 15 years’ worth of evidence for individual, measured gene-to-gene regulatory 
connections (activations or repressions), accumulated from many researchers, together with 
known impacts of anatomically localized signaling events in the embryo, known blastomere 
cleavage planes, and an absolute time step scale, to create a sophisticated Boolean model 
(Peter, Faure, and Davidson 2012). When computed from time zero of fertilization to 30 hr 
of development, this model accurately reproduced the vast majority of known gene 
expression data in this embryo (Peter, Faure, and Davidson 2012).
This is a triumph for the building-out approach, but its solution has been highly labor-
intensive. Furthermore, it retains some reservations. One is that it is not strictly proven to be 
complete, lacking full genome-wide analysis. Also, there are specific features of the early 
embryo system that have been important for making this system soluble in terms of a 
Boolean model, which should be noted.
In life, the operation of the early embryo network is fast and deterministic, and the Boolean 
model takes advantage of this. In embryos developing by “mode 1” embryogenesis like sea 
urchin embryos (Peter and Davidson 2015, ch. 3; Davidson 1991), maternal macromolecules 
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loaded into the egg provide initial polarity and the embryonic fate map is set by canonical 
cleavage planes. Where gene expression requires triggering by an intercellular signal, the 
positions of the cell delivering and the cell receiving the signal in each case are invariant due 
to this reproducible cleavage pattern. In terms of the gene expression linkages themselves, 
there are three key features that characterize this kind of system. First, gene expression 
responds rapidly to any new appearance of activators in the system: there is little if any 
temporal buffering (i.e., as soon as a quorum of needed factors is present). Second, gene 
expression responds to low doses of activator almost identically as to higher doses of 
activator: the system saturates its responses at very low levels of positive regulators (Bolouri 
and Davidson 2003) – although this “rule” is controversial in light of the role of gradients in 
patterning, e.g. (Briscoe and Small 2015; Reeves et al. 2012). Third, when a trans-acting 
factor causes a negative regulatory effect, it tends to silence the target gene, not just 
moderate its expression. This means that transcription factor inputs in the network can be 
treated in a Boolean fashion and can yield digital all-or-none outputs in terms of target gene 
expression, and that the time constants for response leave minimal delay between the 
synthesis of new regulators and the appearance of the response. While these system features 
of the early sea urchin embryo have made the Boolean modeling approach both powerful 
and effective, they are not universal in developmental systems.
4. Stem-cell based development: model for stochastic fate determination 
systems?
In postnatal animals, it is now known that many tissues stockpile cells whose differentiation 
is suspended, but which remain available as a reservoir of precursors for renewal and/or 
repair. These stem cells have been studied longest, and remain best characterized, in the 
hematopoietic system, where it is clear that the stem cells retain both pluripotency (>10 
potential cell-type derivatives, many of them further subspecialized) and an impressive self-
renewal potential. The stem cell differentiation clock is by definition uncoupled from the 
organism’s overall ontogenic clock, in that any given stem cell makes a series of 
independent decisions to further postpone or to undergo differentiation, as long as it is still a 
stem cell, repeatedly and out of synchrony with other stem cells. In the case of 
hematopoietic cells, not only timing but also differentiation pathway choices and 
differentiated cell outputs can be variable. The potential for extensive but variable 
proliferation can further be propagated to lineage-committed blood-cell precursors 
descended from stem cells, like those determined to give rise to dendritic cells, erythroid 
cells, or T lymphocytes (Naik et al. 2013; Perié et al. 2015; Manesso et al. 2013; Yui and 
Rothenberg 2014). Importantly, in between stem cells and committed precursors, a variety of 
highly proliferative developmental intermediates exhibit stereotyped patterns of partial 
lineage restriction, implying that lineage choice occurs by stepwise subtraction of options 
even while fate indeterminacy persists, rather than by coordinated initiation of a particular 
developmental program. All of these features are markedly different from those of mode 1 
developing embryos, and they are associated with specific differences in the operating 
principles of the relevant gene networks.
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These differences emerge from gene networks with important roles for regulator dosage 
sensitivity, conditionality of inter-regulator repression, and a substantial influence of history 
on the range of effects a transcription factor can exert. The combinations of fates that can 
remain open in particular precursors can be traced to expression of transcription factors that 
are necessary for particular fates but which can support other fates, too, at different levels. 
Dosage sensitivity calls for dosage control mechanisms, and it turns out that many of the 
regulatory factors used in hematopoietic differentiation can exert partial damping effects on 
other regulatory genes without silencing them. Finally, the response to a particular 
transcription factor even within a given lineage can be delayed substantially with respect to 
the factor’s synthesis, both due to synthesis and turnover kinetics and due to interactions of 
the factor with slowly changing chromatin conformation states around its target sites. These 
effects add considerable complexity to modeling of causality in gene expression dynamics.
5. Regulator dose dependence in early T-cell development
As multipotent blood cell precursors begin to differentiate toward a T-lymphocyte fate, they 
use a constellation of transcription factors that are partially held over from more pluripotent 
precursors and partially induced de novo by signals presented in the microenvironment of 
the body’s T cell “nursery”, the thymus (Rothenberg et al. 2016; Yui and Rothenberg 2014). 
Among the transcription factors that are crucial for enabling cells to become T cells are a 
relatively T-cell specific factor, GATA-3, a factor used to make T and B lymphocytes, E2A, 
and a factor used for various non-T cell fates as well as the early steps of T-cell 
development, PU.1. In addition, to promote the T-cell fate, the cell needs to be able to use 
the Notch signal response system (the bifunctional Notch1 molecule, plus signal processing 
molecules) to sense signals from the microenvironment. Although the cells express all these 
factors simultaneously, and require all these factors simultaneously, at least two of them are 
capable of poisoning the T-cell program if expressed at somewhat higher levels. PU.1 
expressed at too high a level kills the cells or diverts them to a non-lymphocyte fate, in 
accord with its key role in the same non-lymphoid fates. More surprisingly, the “T-cell 
specific” factor GATA-3 at too high a level also kills the cells or diverts them to a different 
non-lymphocyte fate, converting them to mast cells (Taghon et al. 2007). The reason that 
PU.1 can block T-cell development is in large part due to the ability of high-level PU.1 to 
shut down the effectiveness of the Notch signaling system (Del Real and Rothenberg 2013; 
Champhekar et al. 2015). The reason that high-level GATA-3 can block T-cell development 
appears in part to be due to its ability to shut down PU.1 activity, and in part to its ability to 
mimic roles of a related GATA factor that is normally expressed in the mast cell fate, 
GATA-2 (Scripture-Adams et al. 2014; Taghon, Yui, and Rothenberg 2007).
Dose dependence implies that each factor is titrating some interaction partner or constraint. 
Both PU.1 and GATA-3 have constraints that are normally embedded in the same T-cell 
program in which they work themselves. PU.1 cannot block Notch signaling unless it is 
expressed at a high level. As long as Notch signaling continues, PU.1 can promote 
expression of numerous target genes without extinguishing the T-cell program genes and 
without activating key parts of the non-T myeloid–cell program (Del Real and Rothenberg 
2013). Preliminary results (H. Hirokawa, J. Ungerbäck, and E.V. R., unpublished data) 
suggest that PU.1 protein is expressed at similar levels and binds to similar or identical 
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genomic sites with or without Notch signaling, but that Notch signaling may affect its ability 
to interact with other transcription factors on the DNA to modulate its activity. Thus the 
quantitative balance between PU.1 level and environment-driven Notch signaling intensity 
likely works as a bistable switch to determine whether PU.1 works within the T-cell pathway 
or as a diversion from it (Del Real and Rothenberg 2013). It is a balance between 
continuous-valued regulatory inputs that yields a Boolean output – but it is a mechanism that 
is difficult to use to predict the output of a particular level of PU.1 expression.
The reasons for the extreme toxicity of high-level GATA-3 are not completely defined. 
However, there are several clues. GATA-3 has a non-DNA binding interaction partner, 
FOG-1 (Zfpm1), that is normally expressed at about the same level as GATA-3 in early T 
cells. FOG-1 interaction with GATA family factors usually affects their functionality, either 
to promote activation or to promote repression (Miccio et al. 2010; Letting et al. 2004). If 
this complex has different effects from GATA-3 without FOG-1, then excess GATA-3 could 
be functionally competing with GATA-3/FOG-1 heterodimers for activity at important DNA 
target sites. Alternatively, GATA-3 in excess could bind to an inappropriate spectrum of 
DNA sites for the stage of development. Unlike PU.1, GATA-3 protein is normally recruited 
to different subsets of its target sites from one stage of T-cell development to the next (Zhang 
et al. 2012), even though the levels of GATA-3 protein change very little (Scripture-Adams 
et al. 2014). This probably reflects weak DNA-binding interaction that is stabilized normally 
by contacts with other, locally bound transcription factors, and avoidance of stable binding 
at sites where other factors are not present. Excess GATA-3 could make site occupancy less 
dependent on partners, thus causing incoherent gene regulation responses. One of these 
effects is the aberrant downregulation of PU.1, but excess GATA-3 could be poisoning the T-
cell program through other effects as well.
6. Soft repression in early T cells
The T-cell differentiation program has evolved to be protracted through multiple cell cycles 
before resolving into T-cell lineage commitment, apparently in order to enable each 
precursor to generate large clones of cells that can develop into mature T cells with very 
diverse antigen recognition specificities at later stages of development (Lu et al. 2005). This 
program thus keeps alternative differentiation at bay through 10–12 cell cycles (Manesso et 
al. 2013) despite continuing to use factors, like PU.1, that preserve some possible access to 
other developmental options. A prominent mechanism that may hold the key to this slow 
progression toward commitment is the use of cross-regulation to limit but not to silence 
expression of other regulators. A striking case of this is the way E2A is used. E2A works in 
part as a positive regulator of Notch pathway signaling competence (Yashiro-Ohtani et al. 
2009), and thus sustains the cells’ ability to stay on course for the T-cell program despite 
PU.1 expression. This role fits well with E2A’s continued expression even after PU.1 is 
finally turned off and the cells are committed to T-cell development. More surprisingly, E2A 
turns out to be a significant negative regulator of GATA-3 (Xu et al. 2013), the factor that is 
co-expressed and co-sustained with E2A in the T-cell program long after commitment. It 
turns out that E2A activity is needed to prevent GATA-3 overexpression, and either E2A 
mutation or expression of an E2A antagonist (Id2) can lead to overexpression of GATA-3 
(Xu et al. 2013; Del Real and Rothenberg 2013). If E2A were to silence GATA-3, as 
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generally happens between regulators and antagonistic regulatory genes in embryonic 
boundary formation, it would destroy T-cell development because GATA-3 is so acutely 
required by developing T cells. However, instead it sustains T-cell development by 
preventing GATA-3 levels from rising too high.
Soft repression like this is also seen in responses to high-level PU.1 by a variety of 
regulatory genes that are normally expressed in the same stages as PU.1 (Champhekar et al. 
2015). Single-cell multiplex gene expression analysis is ongoing to verify whether these soft 
repression targets are actually co-expressed with PU.1 in individual cells (W. Zhou, M. A. 
Yui and E. V. R., unpublished data). But the population-level evidence strongly suggests that 
multipotency, while it lasts, is also a kind of mutual nonaggression state enforced by cross-
regulatory damping of expression among sets of co-expressed regulatory genes.
These effects are not easily captured by a predictive gene regulatory network model 
formulation with purely Boolean logic, even though the relationships can be laid out in such 
a topological format (Longabaugh et al. 2017), because the impacts of one regulator on a 
target node can depend on the level of that regulator at a given time relative to the level of 
another regulator. This forces effects like protein half-life regulation and cell cycle time 
(Kueh et al. 2013) to become relevant for predictiveness.
7. History and “memory”: contributions of chromatin state to regulatory 
dynamics
Underlying the gene regulatory network models of early embryo development is an 
assumption that gene expression should be a fairly immediate response to the “regulatory 
state” as defined by the transcription factors that are currently present in the cell. The actual 
time scale defined as “fairly immediate” is variable depending on features of different 
embryos, for example the temperature at which the organism normally develops. Response 
times (“step times” from transcription factor gene activation to target gene activation) can 
range from ~15 min in the case of the fruit fly, Drosophila melanogaster (Clark and Akam 
2016), to ~3 hr in the case of the sea urchin, Strongylocentrotus purpuratus (Bolouri and 
Davidson 2003; Peter, Faure, and Davidson 2012). However, the validation of a network 
architecture is defined by the ability to account for changes in target gene expression from 
one time point to the next in terms of changes in the transcription factors that are present at 
those times.
Development of hematopoietic cells from pluripotent precursors in mammals is shockingly 
slow in this context, requiring days to make transitions from one step to the next 
recognizable step. This could have different explanations. The step times could in fact be 
shorter, but hard to recognize if the right indicator genes were not being followed. 
Alternatively, the cross-regulatory damping influences among different regulators could 
keep the cells in a kind of gene network “Brownian motion” with only occasional, random 
cells escaping into forward developmental progression. However, a third possibility is that 
the initial state of the cells is fundamentally different if they emerge from a dedicated stem-
cell progenitor than if they emerge from a fertilized egg. The hematopoietic stem cell is 
known to be in itself a specialized cell type that is only produced at a relatively late stage in 
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the embryo, not a naïve cell type set aside from the earliest stages of development (Dzierzak 
and Speck 2008; Boïers et al. 2013). It is prevented from differentiating while the rest of the 
embryo differentiates. Thus, it is possible that the stem cell history of late-fetal and postnatal 
hematopoietic cells interposes the task of dismantling the stem cell state before 
differentiation can be unleashed.
This kind of generic possibility could be reflected in chromatin state modifications, for 
example, the methylation of DNA and/or the compaction or polycomb repression of 
chromatin at key regulatory sites for differentiation genes. However, even if hematopoietic 
stem cells could be shown to have more “repressive marks” on their chromatin than early 
cleavage-stage embryonic cells, that would not in itself predict quantitatively how much of a 
delaying effect such repression mechanisms would be expected to have on differentiation. It 
is clear that “epigenetic marks” like this can be removed as well as installed at specific 
genomic sites as a result of transcription factor action (e.g. Ji et al. 2010; Zhang et al. 2012; 
rev. in Rothenberg 2013). Could a cell’s history actually affect gene network dynamics?
Evidence to support this interpretation has come from a close analysis of the activation of a 
regulatory gene, Bcl11b, that occurs precisely as pro-T cells undergo commitment (Kueh et 
al. 2016). The Bcl11b gene product is needed for the commitment process to occur normally 
(Ikawa et al. 2010; Li, Leid, et al. 2010; Li, Burke, et al. 2010), and its expression is delayed 
for several days after Notch signaling induces expression of other regulators, including 
GATA-3 and another T-cell-associated factor, TCF-1. By causing the Bcl11b gene to drive 
the expression of a fluorescent protein as well as the normal Bcl11b protein, it has been 
possible to use live-cell imaging to examine what it takes for individual cells to cross the 
threshold to activate this gene. Once expressed in a given cell, the Bcl11b gene is 
overwhelmingly likely to remain expressed, and its expression is found to depend on at least 
four positive regulatory inputs: Notch signaling, the T-cell factors GATA-3 and TCF-1, and a 
factor with gently increasing expression from the stem cell stage, Runx1/CBFβ (Kueh et al. 
2016). Knocking down any of these factors blocks the ability of the cell to activate Bcl11b. 
However, the kinetics of Bcl11b gene activation do not follow the expression patterns of 
these inputs together, and nor do they follow the time window of sensitivity to loss of 
activity of these factors as a whole. All four factors are expressed days and multiple cell 
cycles before Bcl11b turns on, and if they are removed at that early stage, the activation of 
Bcl11b indeed is blocked. But if cells at the stage immediately prior to Bcl11b activation are 
deprived of these inputs, three of four are partially or completely dispensable for the 
response, including Notch signaling and the two most T-cell specific inputs. Instead, these 
factors appear to be involved in a licensing process that slowly makes the Bcl11b gene 
eligible for expression. The factor that is immediately engaged in controlling Bcl11b 
expression and expression amplitude, both during activation and long afterwards in mature T 
cells, is none of these lineage-specific inputs. Instead, it is the multilineage, ancestrally 
inherited factor, Runx1/CBFβ (Kueh et al. 2016).
The key to the delay is that Bcl11b in stem cells and in the earliest T-cell precursors is 
completely repressed, with its DNA methylated and its chromatin marked with repressive 
histone marks. A complex process involving a far-distal enhancer, nearly a million base pairs 
away in the genome (Li et al. 2013), is required to activate it, by removing these repressive 
Rothenberg Page 9
Hist Philos Life Sci. Author manuscript; available in PMC 2017 October 29.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
mechanisms in a way that only finishes at the time the gene is activated (Li et al. 2013). 
Presumably for this reason, the Runx1/CBFβ factor, although present from the start, 
apparently cannot work on the Bcl11b locus until after the licensing event (dependent on 
Notch, GATA-3, and TCF-1) and a slow gene-accessibility process have become complete, 
over a period of ~4 days. Separate evidence for the nature of this slow process comes from 
further analysis using two different colored fluorescent reporters to track the two alleles in 
the same cells (K. K. H. Ng, M. A. Yui, S. S. Pease, S. Siu, A. Mehta, E. V. Rothenberg, H. 
Y. Kueh, unpublished). If the delay were only due to the lack of some other, as yet 
unidentified transcription factor, then both alleles would be activated in parallel. However, in 
fact they can be activated quite asynchronously in many of the cells. This shows that the 
slow step is of a kind that can work on each chromosome separately, even in the same cell 
where both chromosomes are exposed to the same transcription factors. The need for this 
slow process in the Bcl11b case is thus a measure of the resilience of the silencing 
mechanism inherited from the stem cell ancestor that has to be undone in order for the cells 
to complete T-cell commitment. This is quite different from the behavior of differentiation 
genes in an embryonic cell undergoing initial specification in most well-studied systems.
8. Operating principles of a T-cell specification network
The distinctive features of regulatory gene product interactions with other regulatory genes 
and with the chromatin state of key genomic loci in mammalian hematopoiesis do not 
supplant central features of gene network architecture, including the roles of combinatorial 
action of transcription factors on key targets. However, they change the relationship between 
the activation of an “upstream regulator” gene and a “downstream target” gene, in temporal 
response and in conditionality upon dosage. We suggest that part of the delay, at least, is due 
to the pre-existing chromatin states of genes in the dedicated stem and progenitor cell 
populations. Opening or closing a gene can require transcription factor actions on multiple 
different genomic regions that gain or lose accessibility through a slow process. The system 
makes use of this delay to enable cells to proliferate extensively, even after key transcription 
factors have been activated, before completing commitment to a particular developmental 
pathway. Because of the dosage control, the same transcription factor can participate in 
multiple different programs, where its effect is modulated by levels of other factors. Most 
importantly, in this system the repression of one set of factors by another often occurs only 
at high doses of the repressing factor, either due to biochemistry of factor/site interaction or 
due to gene network circuitry. Thus, in these early T precursors, coexpression of two factors 
that are supposed to be mutual antagonists, like PU.1 and GATA factors (Huang et al. 2007; 
Nerlov et al. 2000; Rekhtman et al. 1999; Zhang et al. 1999), can persist through many cell 
cycles before their “opposition” is manifest.1 The de-emphasis on silencing-type repression 
significantly increases the number of transcription factors that are able to work 
combinatorially to define distinct developmental stages and/or developmental pathways.
1The relationship between GATA-3 and PU.1 in early T cell precursors resembles the relationship between GATA-2 and PU.1 in mast 
cells, and contrasts with the early programming for divergent regulation of GATA-1 and PU.1 seen in other multipotent progenitor 
subsets (Hoppe et al. 2016)
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This set of properties fits the job that mammalian hematopoiesis has evolved to do. This is a 
system in which a dazzling variety of cell types is generated. The T-cell subtypes alone run 
to at least a dozen in mice, and their close cousins the Innate Lymphoid Cells have only 
recently begun to have their own diversity revealed. Dendritic cells, macrophages, and a 
whole range of cell types that share key regulators in violation of a “myeloid” vs. 
“erythroid” dichotomy are being discovered to have comparable diversity that is important 
physiologically. The diversity of possible outcomes is matched by a relaxation of temporal 
constraints and population size constraints, both of which are “outsourced” to physiological 
cues from the body’s environment. Prolonged multipotentiality, indeterminacy of 
commitment timing, and flexible use and re-use of the same transcription factors in 
divergent but related programs even at the expense of crispness of specification, thus become 
virtues in this system.
Concluding Remarks
Development is the most obvious output of genomic regulatory network operation, yet the 
analytical and predictive models that capture essential features of these networks need to be 
considered separately for different modes of development. The importance of quantitative 
effects on target gene expression as opposed to qualitative ones, the precision of timing of 
state changes, and the nature of negative regulation can all differ considerably between 
biological systems. Here we have focused on two developmental systems that have evolved 
to optimize different desiderata: the sea urchin embryo system and the mammalian postnatal 
hematopoietic system. The sea urchin embryo is highly precise and accurate about both cell 
fate determination and timing of differentiation of every cell type in the embryo, and has 
evolved to accomplish this by relative insensitivity to absolute levels of expression of key 
regulators. The mechanisms that make this possible are embedded in the prevalence of 
positive feed-forward circuits in its network architecture and in the all-or-none form that 
repression takes in this system. In contrast, the mammalian hematopoietic system has 
evolved to emphasize plasticity and environmental responsiveness at the expense of 
precision in both timing and cell fate determinism. The networks involved in this system are 
remarkably sensitive to the levels of different regulators, slow to resolve into end states, and 
permissive of coexpression of mutually antagonistic regulators as long as neither one is too 
highly expressed. These features arise not only from a strong role of chromatin structural 
constraint but also from incoherent feedback architecture of genetic network circuit elements 
in hematopoiesis and a prevalence of incomplete, amplitude-damping type repression. In this 
review, these contrasts have been used to illustrate both the richness of possible gene 
network behaviors, and the challenge to biologists to understand the operation of 
developmental networks in terms of models that capture the operational essences of the 
individual biological systems.
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